Cardlytics, INC 8-K filings

NASDAQ

14 Mar 2024

CDLX

8-K: Cardlytics Achieves Positive Adjusted EBITDA for Full Year 2023, Eyes Double-Digit Billings Growth in 2024

Cardlytics reports its first full year of positive Adjusted EBITDA since 2019, driven by revenue growth and cost structure rebalancing.

NASDAQ

29 Jan 2024

CDLX

Cardlytics, INC

8-K: Cardlytics Resolves Bridg Merger Dispute, Announces Positive Preliminary Q4 Results

Cardlytics has settled its dispute with Shareholder Representative Services (SRS) regarding the Bridg merger earnout payments and announced preliminary positive financial results for the fourth quarter of 2023.